- Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study
-
Park SJ, Kim J, Kim HS, Lee JW, Chang HK, Lee KH, Kim DY, Kim S, Chang SJ, Han SS, Park SY, Shim SH
- KMID: 2470868
- J Gynecol Oncol.
- 2020 Mar;31(2):e15.
- doi: 10.3802/jgo.2020.31.e15
OBJECTIVE: To evaluate the effectiveness and safety of the combination of pegylated liposomal doxorubicin with carboplatin (CD) compared with those of carboplatin and paclitaxel (CP) for platinum-sensitive recurrent ovarian, fallopian,... -
- CITED
-
- Close
- SHARE
-
- Close
- Adult Ileocolic Intussusception Caused by Diffuse Large B Cell Lymphoma
-
Park JW, Song GA, Baek DH, Kim GH, Lee BE, Lee MW, Han SY, Park YJ, Park EY
- KMID: 2471139
- Korean J Gastroenterol.
- 2020 Jan;75(1):46-49.
- doi: 10.4166/kjg.2020.75.1.46
Intussusception is a medical condition, in which a proximal part of the intestine folds into the distal intestine. Adult intussusceptions are rare and account for approximately 5% of all cases... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Effects of Hypomethylating Agents in Patients with Newly Diagnosed Myelodysplastic Syndrome Who Received DNA-Damaging Chemotherapy for Metastatic Breast Cancer
-
Baek DW, Lee SJ, Sohn SK, Moon JH, Chae YS
- KMID: 2470901
- J Breast Cancer.
- 2019 Dec;22(4):647-652.
- doi: 10.4048/jbc.2019.22.e50
The cumulative risk of therapy-related myelodysplastic syndrome (t-MDS) in breast cancer patients exposed to chemotherapy and/or radiotherapy is significantly high compared to that in other cancer patients. This report reviews... -
- CITED
-
- Close
- SHARE
-
- Close
- Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy
-
Shin JJ, Choi YM, Jun JK, Lee KH, Kim TY, Han W, Im SA
- KMID: 2470898
- J Breast Cancer.
- 2019 Dec;22(4):624-634.
- doi: 10.4048/jbc.2019.22.e53
PURPOSE: The probability of ovarian failure after cytotoxic chemotherapy in patients with breast cancer has not been well established in Korea. This study aimed to assess the rate of ovarian... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of Febrile Neutropenia in Advanced Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy in Korea and Its Impact on Prognosis
-
Park BK, Gwak H, Lim ST, Suh YJ, Jeon YW
- KMID: 2470609
- J Breast Dis.
- 2019 Dec;7(2):97-104.
- doi: 10.14449/jbd.2019.7.2.97
PURPOSE: The concurrent regimen of docetaxel, doxorubicin, and cyclophosphamide (TAC) has been categorized as a high-risk factor for febrile neutropenia (FN). The incidence of FN was reported to be as... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure
-
Oh CM, Cho S, Jang JY, Kim H, Chun S, Choi M, Park S, Ko YG
- KMID: 2464299
- Korean Circ J.
- 2019 Dec;49(12):1183-1195.
- doi: 10.4070/kcj.2019.0180
BACKGROUND AND OBJECTIVES: Recent studies have shown that sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of heart failure (HF)-associated hospitalization and mortality in patients with diabetes. However, it is... -
- CITED
-
- Close
- SHARE
-
- Close
- Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
-
Kim HS, Lee JS, Lee HK, Park EJ, Jeon HW, Kang YJ, Lee TY, Kim KS, Bae SC, Park JH, Han SB
- KMID: 2461200
- Immune Netw.
- 2019 Oct;19(5):e36.
- doi: 10.4110/in.2019.19.e36
Mesenchymal stem cells (MSCs) ameliorate the renal injury in Adriamycin (ADR)-induced nephropathy, but the mechanisms underlying their efficacy remain incompletely understood. In this study, we demonstrated that MSCs increased the... -
- CITED
-
- Close
- SHARE
-
- Close
- Sorafenib-induced Pancreatic Pseudocyst in a Patient with Advanced Hepatocellular Carcinoma: a Rare Adverse Event
-
Kim DH, Kim M, Yim HJ, Suh SJ, Jung YK
- KMID: 2463617
- J Liver Cancer.
- 2019 Sep;19(2):154-158.
- doi: 10.17998/jlc.19.2.154
A 54-year old man diagnosed with advanced hepatocellular carcinoma began treatment with sorafenib. After 3 weeks of treatment, he complained of abdominal pain and nausea. Abdominal sonography showed multiple hepatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Flavestin K, An Isoprenylated Stilbene from the Leaves of Macaranga recurvata Gage
-
Tjahjandarie TS, Tanjung M, Saputri RD, Nadar PB, Aldin MF, EvaMarliana , Permadi A
- KMID: 2459967
- Nat Prod Sci.
- 2019 Sep;25(3):244-247.
- doi: 10.20307/nps.2019.25.3.244
A new isoprenylated stilbene, flavestinK (1) together with two known isoprenylated stilbenes, flavestin B (2), flavestin G (3), and two isoprenilated flavanones, 4-O-methyl-8-isoprenylnaringenin (4) and 8-isoprenyl-5,7-dihydroxyflavanone (5) were isolated from... -
- CITED
-
- Close
- SHARE
-
- Close
- Theranostics Based on Liposome: Looking Back and Forward
-
Lee W, Im HJ
- KMID: 2455518
- Nucl Med Mol Imaging.
- 2019 Aug;53(4):242-246.
- doi: 10.1007/s13139-019-00603-z
Liposome is one of the oldest yet most successful nanomedicine platforms. Doxil®, PEGylated liposome loaded with doxorubicin (DOX), was approved by the FDA in 1995 for the treatment of AIDS-related... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP
-
Cho KM, Keam B, Ha H, Kim M, Jung JW, Song WJ, Kim TM, Jeon YK, Kang HR, Kim DW, Kim CW, Heo DS
- KMID: 2457319
- Korean J Intern Med.
- 2019 Jul;34(4):885-893.
- doi: 10.3904/kjim.2017.036
BACKGROUND/AIMS: This study was to evaluate the clinical significance of infusion-related reaction (IRR) of rituximab in diffuse large B-cell lymphoma (DLBCL) patients who received R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Acquired Reactive Perforating Collagenosis as a Preceding Manifestation of Hodgkin's Lymphoma
-
Lee SY, Bang CH, Park YM, Lee JY, Lee JH
- KMID: 2454375
- Korean J Dermatol.
- 2019 Jul;57(6):332-334.
A 40-year-old man presented with pruritic, multiple, variable-sized, erythematous umbilicated papules on the trunk and both extremities for 4 months. He was diagnosed with Hodgkin's lymphoma (stage IIA) after histopathologic... -
- CITED
-
- Close
- SHARE
-
- Close
- Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
-
Li X, Huang H, Xu B, Guo H, Lin Y, Ye S, Yi J, Li W, Wu X, Wang W, Zhan H, Xie D, Peng J, Cao Y, Pu X, Guo C, Hong H, Wang Z, Fang X, Zhou Y, Lin S, Liu Q, Lin T
- KMID: 2454284
- Cancer Res Treat.
- 2019 Jul;51(3):919-932.
- doi: 10.4143/crt.2018.230
PURPOSE: Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone administered every 3 weeks (R-CHOP-21) is the standard care for diffuse large B-cell lymphoma (DLBCL). It is unknown whether the dose-dense R-CHOP... -
- CITED
-
- Close
- SHARE
-
- Close
- Olaratumab and doxorubicin for the treatment of metastatic soft tissue sarcoma: a retrospective case series
-
Hur JY, Park SH, Lee SJ
- KMID: 2469530
- Precis Future Med.
- 2019 Jun;3(2):77-84.
- doi: 10.23838/pfm.2019.00016
PURPOSE: Soft tissue sarcomas (STS) are a rare and heterogeneous tumor group with limited treatment options. This study aimed to evaluate the anti-tumor efficacy of olaratumab and doxorubicin in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Stem cell analysis with intraductally treated mammary epithelial cells
-
Yoon AY, Kim YY, Lee JH, Chung YS, Choi S, Kang JM, Park HK, Chun YS
- KMID: 2452896
- Korean J Clin Oncol.
- 2019 Jun;15(1):27-33.
- doi: 10.14216/kjco.190027
PURPOSE: The activity of mammary stem cells (MaSCs) is essential to mammary growth, differentiation and regeneration in cycles of pregnancy, lactation, and involution. The capability to recruit the mammary gland... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer
-
Gao J, Deng F, Jia W
- KMID: 2450115
- J Breast Cancer.
- 2019 Jun;22(2):196-209.
- doi: 10.4048/jbc.2019.22.e23
PURPOSE: Breast cancer has become a major public health threat in the current society. Anthracycline doxorubicin (DOX) is a widely used drug in breast cancer chemotherapy. We aimed to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC Pathway
-
Liu CL, Chen MJ, Lin JC, Lin CH, Huang WC, Cheng SP, Chen SN, Chang YC
- KMID: 2450114
- J Breast Cancer.
- 2019 Jun;22(2):185-195.
- doi: 10.4048/jbc.2019.22.e22
PURPOSE: Cancer cells develop acquired resistance induced by chemotherapeutic drugs. In this study, we investigated the effects of brief treatment with cytotoxic drugs on the phenotype of breast cancer cells. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
-
Kim GM, Kim JH, Kim JH, Cho YU, Kim SI, Park S, Park HS, Kim JY, Sohn J
- KMID: 2464426
- Cancer Res Treat.
- 2019 Apr;51(2):812-818.
- doi: 10.4143/crt.2018.383
PURPOSE: Dose-dense chemotherapy (DD-CT) is a preferred (neo)adjuvant regimen in early breast cancer (BC). Although the results of reported randomized trials are conflicting, a recent meta-analysis showed improved overall and... -
- CITED
-
- Close
- SHARE
-
- Close
- Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-Related Cardiotoxicity in Patients with Breast Cancer: A Study Using 13 Years of Registry Data
-
Kim EK, Cho J, Kim JY, Chang SA, Park SJ, Choi JO, Lee SC, Ahn JS, Park SW, Im YH, Jeon ES, Park YH
- KMID: 2464418
- Cancer Res Treat.
- 2019 Apr;51(2):727-736.
- doi: 10.4143/crt.2018.262
PURPOSE: While concerns regarding trastuzumab-related cardiac dysfunction (TRCD) in patients with breast cancer are increasing, there is a lack of evidence supporting the current recommendations for TRCD monitoring. We aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Ewing Sarcoma
-
Ju HY
- KMID: 2449228
- Clin Pediatr Hematol Oncol.
- 2019 Apr;26(1):27-34.
- doi: 10.15264/cpho.2019.26.1.27
Ewing sarcoma is the second most frequently occurring malignant tumor of the bone and soft tissue in adolescents and young adults. Genetically, Ewing sarcoma is characterized by balanced chromosomal translocation... -
- CITED
-
- Close
- SHARE
-
- Close
